Skip to main content

Stonepine Capital Management, LLC

Position in NKTR — Nektar Therapeutics

CIK 1440771 BEND, OR

Position in NKTR

as of Jun 30, 2026 · filed Aug 17, 2026
Position Value
$8,422,855
+$2,307,105 QoQ
Shares Held
120,654
+41.9% QoQ
Ownership
0.353%
of shares outstanding
% of Portfolio
6.41%
of 13F equity value
Holder Rank
#49
of 240 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NKTR Over Time

Shares Held

Position Value (USD)

Derivatives in NKTR

reported options exposure · as of Dec 31, 2025
CallValue
$2,114,000
CallShares
50,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Stonepine Capital Management, LLC holds $108,574,607 across 61 Biotechnology names. NKTR ranks #3 (7.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NKTR
Nektar Therapeutics
This page
120,654 $8,422,855

All Filings in NKTR

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,422,855 120,654
2026-03-31 $6,115,750 85,000
2025-12-31 $2,114,000 50,000
2025-12-31 $3,593,800 85,000
2025-09-30 $4,836,500 85,000
2025-06-30 $1,297,168 50,200
2024-03-31 $3,236,780 3,480,409